Sustained Reduction of Blood Pressure with Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up

Hypertension

Volumn 69, Issue 5, 2017, Pages 836-843

  De Leeuw, Peter W ^a,b   Bisognano, John D ^c   Bakris, George L ^d   Nadim, Mitra K ^e   Haller, Hermann ^f   Kroon, Abraham A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

baroreflex; blood pressure; heart failure; hypertension; pressoreceptors

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGE; ARTICLE; BAROREFLEX ACTIVATION THERAPY; BLOOD PRESSURE REGULATION; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COMORBIDITY; DIASTOLIC BLOOD PRESSURE; ELECTROSTIMULATION; FEMALE; FOLLOW UP; HEART RATE; HEMATOMA; HUMAN; HYPERTENSIVE CRISIS; HYPOTENSION; IMPLANTABLE PULSE GENERATOR; KIDNEY DENERVATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSE PRESSURE; RACE; RESISTANT HYPERTENSION; SEIZURE; SEX; SYSTOLIC BLOOD PRESSURE; URINARY TRACT INFECTION; AGED; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ELECTROTHERAPY; HYPERTENSION; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BAROREFLEX; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRESSORECEPTORS; TREATMENT OUTCOME;

EID: 85015716605     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.117.09086     Document Type: Article

References (25)

1. Schmidli J, Savolainen H, Eckstein F, Irwin E, Peters TK, Martin R, Kieval R, Cody R, Carrel T, Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular 2007 15 63-69. doi: 10.2310/6670.2007.00024.
2. Illig KA, Levy M, Sanchez L, Trachiotis GD, Shanley C, Irwin E, Pertile T, Kieval R, Cody R, An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg 2006 44 1213 1218. doi: 10.1016/j.jvs.2006.08.024.
3. Scheffers IJ, Kroon AA, Schmidli J, Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 2010 56 1254 1258. doi: 10.1016/j.jacc.2010.03.089.
4. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA, Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos Pivotal trial. J Am Coll Cardiol 2011 58 765 773. doi: 10.1016/j.jacc.2011.06.008.
5. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM, Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008 51 1403 1419. doi: 10.1161/HYPERTENSIONAHA.108.189141.
6. Tordoir JH, Scheffers I, Schmidli J, Savolainen H, Liebeskind U, Hansky B, Herold U, Irwin E, Kroon AA, de Leeuw P, Peters TK, Kieval R, Cody R, An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg 2007 33 414-421. doi: 10.1016/j.ejvs.2006.11.025.
7. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2013 31 1281-1357. doi: 10.1097/01.hjh.0000431740.32696.cc.
8. Oldham PD, A note on the analysis of repeated measurements of the same subjects. J Chronic Dis 1962 15 969-977
9. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, SYMPLICITY HTN-3 Investigators A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014 370 1393 1401. doi: 10.1056/NEJMoa1402670.
10. Mahfoud F, Tunev S, Ewen S, Cremers B, Ruwart J, Schulz-Jander D, Linz D, Davies J, Kandzari DE, Whitbourn R, Böhm M, Melder RJ, Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J Am Coll Cardiol 2015 66 1766-1775. doi: 10.1016/j.jacc.2015.08.018.
11. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP, Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013 61 457-464. doi: 10.1161/HYPERTENSIONAHA.111.00194.
12. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichlmaier AM, Luft FC, Jordan J, Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010 55 619-626. doi: 10.1161/HYPERTENSIONAHA.109.140665.
13. Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, Cates AW, Lovett EG, Haller H, Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens 2012 6 270-276. doi: 10.1016/j.jash.2012.04.004.
14. Wallbach M, Lehnig LY, Schroer C, Lüders S, Böhning E, Müller GA, Wachter R, Koziolek MJ, Effects of baroreflex activation therapy on ambulatory blood pressure in patients with resistant hypertension. Hypertension 2016 67 701-709. doi: 10.1161/HYPERTENSIONAHA.115.06717.
15. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G, Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988 11 3-20
16. Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Böhm M, Mahfoud F, Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension. Hypertension 2015 65 193-199. doi: 10.1161/HYPERTENSIONAHA.114.04336.
17. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI, Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986 73 615-621
18. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J, The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009 54 1747-1762. doi: 10.1016/j.jacc.2009.05.015.
19. Parati G, Esler M, The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 2012 33 1058-1066. doi: 10.1093/eurheartj/ehs041.
20. Gronda E, Seravalle G, Brambilla G, Costantino G, Casini A, Alsheraei A, Lovett EG, Mancia G, Grassi G, Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail 2014 16 977-983. doi: 10.1002/ejhf.138.
21. Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Müller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC, Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail 2015 3 487-496. doi: 10.1016/j.jchf.2015.02.006.
22. Patel P, Gupta PK, White CM, Stanley AG, Williams B, Tomaszewski M, Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation. J Hum Hypertens 2016 30 368-373. doi: 10.1038/jhh.2015.103.
23. Gupta P, Patel P, Horne R, Buchanan H, Williams B, Tomaszewski M, How to screen for non-adherence to antihypertensive therapy. Curr Hypertens Rep 2016 18 89. doi: 10.1007/s11906-016-0697-7.
24. van Onzenoort HA, Verberk WJ, Kroon AA, Kessels AG, Neef C, van der Kuy PH, de Leeuw PW, Electronic monitoring of adherence, treatment of hypertension, and blood pressure control. Am J Hypertens 2012 25 54-59. doi: 10.1038/ajh.2011.153.
25. Izawa MR, French MD, Hedge A, Shining new light on the Hawthorne illumination experiments. Hum Factors 2011 53 528-547. doi: 10.1177/0018720811417968.